Home / Biopharma / Stocks Cheering Investors with Mouthwatering Dividend: Cogentix Medical, Inc. (NASDAQ:CGNT), GW Pharmaceuticals plc (NASDAQ:GWPH)

Stocks Cheering Investors with Mouthwatering Dividend: Cogentix Medical, Inc. (NASDAQ:CGNT), GW Pharmaceuticals plc (NASDAQ:GWPH)

Cogentix Medical, Inc. (NASDAQ:CGNT) persists its position slightly strong in context of buying side, while shares price rose 50.83% during latest trading session.

Cogentix Medical, Inc. (CGNT) revealed that it has entered into a securities purchase agreement with Accelmed Growth Partners, L.P.  Under the terms of the securities purchase agreement, Accelmed would purchase $25 million of Cogentix Medical common stock from the Company at $1.55 per share, a 29% premium over the closing price of the stock on September 6, 2016 and a premium of 36% over the average closing price over the last 30 days.  The securities purchase agreement is subject to various closing conditions, including approval by the shareholders of Cogentix Medical.  Accelmed is a premier capital resource for the medical device industry and is based in New York, NY and Hertzeliya, Israel.  Cogentix would apply the proceeds to working capital as well as the implementation of a business development strategy to acquire growth technologies addressing the urology market.

Narrow down focus to other ratios, the co has current ratio of 2.70 that indicates if CGNT lies in 1.3% to 3% then it is acceptable for both active and passive investors, but sometimes its varies industry to industry. Generally, it indicates good short-term financial strength. Street is more conscious on this after SunEdison, Inc. case. To make strengthen these views, the active industry firm has Quick Ratio of 1.80, which indicates firm has sufficient short-term assets to cover its immediate liabilities. In addition, the firm has debt to equity ratio of 0.00, sometimes its remain same with long term debt to equity ratio.

Following previous ticker characteristics, GW Pharmaceuticals plc (NASDAQ:GWPH) also run on active notice, stock price shows upbeat performance surged 23.55% after traded at $104.03 in most recent trading session.

GWPH has price to earnings ratio stands at unstated figure and the price to current year EPS stands at -159.60%. Whereas the traders who further want to see about this, may be interested to see Price to next year’s EPS that would be 1.50%. Moving toward ratio analysis, it has current ratio of 6.10 and quick ratio was calculated as 6.00. The debt to equity ratio appeared as 0.02 for seeing its liquidity position.

Taking notice on volatility measures, price volatility of stock was 6.81% for a week and 4.52% for a month. The price volatility’s Average True Range for 14 days was 3.96. On these bases, analysts would recommend this stock as an “Active Revolving Stocks.” The firm attains analyst recommendation of 2.10 out of 1-5 scale with week’s performance of 27.22%. GWPH’s institutional ownership was registered as 61.20%.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Check Also

Hot Fact Under Analysts Views: AbbVie Inc. (NYSE:ABBV), Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS)

AbbVie Inc. (NYSE:ABBV) [Trend Analysis] retains strong position in active trade, as shares scoring -0.21% …

Leave a Reply

Your email address will not be published. Required fields are marked *